Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Explore value oriented index funds retirement to identify cost-effective options and build a sustainable retirement portfolio. This intro covers why low fees matter and how to start aligning funds with long-term goals.
23,917 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Reddit still furious about AT&T's $47 billion write-down lingers as a new buyer group targets the legacy assets for r...
Backlogs can power stock moves, but they also raise questions about execution, risk, and long-term profitability. Thi...
A timely tribute to Ted Turner and the daring moves that built a media empire. From billboard prince to cable mogul, ...
Zeta Global is accelerating its AI-powered strategy, unlocking new growth channels and investor potential. This artic...
A landmark $1.5 billion bet on counter-drone tech sets Motorola Solutions up for deeper public-safety leadership. Her...
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
As Netflix faces slowing growth, the question on investors' minds is simple: could the streamer be about to buy somet...
Warren Buffett’s transition at Berkshire Hathaway ushers in a new era. Yet three longtime favorites—Apple, American E...
Celebrity headlines can sway our wallets. This article digs into the money lessons behind the buzz, offering actionab...
The Real Brokerage announces its REMAX deal, with CEO Tamir Poleg outlining how the combined platform could monetize ...
Artificial intelligence is reshaping how companies operate and profit. This article breaks down how AI is fueling ear...